• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

ASI UK Income Equity Fund I Acc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Aberdeen Standard Fund Managers Limited
Fund Summary To generate income and some capital over the long term (5 years or more) by investing in UK equities (company shares).Performance Target: To achieve the return of the FTSE All-Share Index plus 3% per annum over three years (before charges). The Performance Target is the level of performance that the management team hopes to achieve for the fund. There is however no certainty or promise that they will achieve the Performance Target.The ACD believes this is an appropriate target for the fund based on the investment policy of the fund and the constituents of the index.
SEDOL code B0XWN92
ISIN GB00B0XWN929
Fund code ABEQT
Managers Charles Luke
Manager Tenure 4 years
Morningstar Category UK Equity Income
IMA Sector UK Equity Income
Fund Size £146 million
Fund Type OEIC
Management Style Active
Ongoing Charge Figure (OCF) 0.87%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £13.3602
Buy Price £13.3602
Price Change +0.0397%
Price Date 8th July 2020
Yield 4.49%
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 30th May 2013
Fund Status OPEN
Charles Luke is a Senior Investment Manager on the UK and European Equities Team having joined Aberdeen in 2000. Charles started his career at Framlington Investment Management in 1998, covering UK equities. Charles graduated with a BA in Economics and Japanese Studies from Leeds University and an MSc in Business and Economic History from the London School of Economics.

3-year Mean Monthly Return: 0.124%

Annual Returns 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Fund Performance -4.37% +4.67% +1.41% +18.04% -0.50% -1.33% +11.50% +20.22% +1.58% +26.72%
Benchmark Performance
(UK Equity Income)
-14.88% -2.76% +5.09% +18.47% -1.43%
Time Period Cumulative Benchmark Performance
(UK Equity Income)
Fund Compared to Benchmark
1 day -1.02% -21.19% +20.16%
1 week -0.12% -5.28% +5.16%
1 month -1.70% +8.77% -10.46%
3 months 8.93% -21.13% +30.07%
6 months -13.01% -16.06% +3.05%
1 year -6.25% -4.71% -1.54%
3 years 0.77% +0.41% +0.36%
5 years 3.88% +6.30% -2.42%
10 years 7.32% +8.47% -1.16%
YTD -12.70% +0.50% -13.20%
Since inception 8.38% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
AstraZeneca PLC GBR 4.39%
GlaxoSmithKline PLC GBR 3.96%
British American Tobacco PLC GBR 3.62%
RELX PLC GBR 3.57%
Diageo PLC GBR 3.52%
Unilever PLC GBR 3.33%
BHP Group PLC GBR 3.30%
Rio Tinto PLC GBR 3.05%
National Grid PLC GBR 3.05%
Assura PLC GBR 2.74%
Dividend Date Per share amount Reinvestment Price
3rd February 2020 0.2485 £15.1213
1st August 2019 0.3459 £14.2903
1st February 2019 0.2175 £12.6049
1st August 2018 0.3209 £13.4736
1st February 2018 0.1796 £13.0730
1st August 2017 0.3146 £13.0407